Polymer drugs of paclitaxel binding by national patent

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) January 14, 2011 -- By the researcher of Chinese Academy of Sciences,fine chemicals , Changchun JING Xia-bin, who invented the "amphiphilic triblock copolymer - drug paclitaxel and synthetic methods of bonding. " patent, recently won the national invention patent

Is recognized as first-line paclitaxel chemotherapy drugs,Lead Citrate, but because the source is limited,CAS 1679-53-4 , expensive, have severe allergic reactions, many patients can not or should not be used.

In the past few years, the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry JING Xia-bin Task Force developed with independent property rights in order to lactic acid polymer amphiphilic block copolymers as the carrier polymer bonded drug paclitaxel. Drug taxol from the fundamental solution to the problem of allergic reactions,10-Hydroxydecanoic Acid , is expected to replace the current clinical use of paclitaxel formulations. As a result of chemical drug molecules covalently linked to the carrier polymer, and the formulation has been successful in avoiding physical coated micelle other early burst release phenomenon. Source: http://www.mhcfm.com

Fine Chemicals